Low float stocks are often very volatile and are well known for making explosive upside moves. Stock traders will often flock to such stocks for no reason other than the fact that they have a low float and the price can potentially move up very quickly. Cellectar Biosciences Inc. (CLRB) turns bullish with gain ... The shares outstanding are 9.39M, and float is at 9.31M with Short Float at 3.35%. Institutions hold 33.62% of the Float. Cellectar Biosciences Inc. (CLRB) Insider Activity. A total of 0 insider transactions have happened at Cellectar Biosciences Inc. (CLRB) in the last six months, with sales accounting for 0 and purchases happening 0 times. Cellectar Biosciences PDC Delivery Platform May Advance ...
Cellectar BioSciences (CLRB) Stock Price History | wallmine Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro metastatic disease; CLR 124 which could detects tumors and metastases in a broad range of cancers; and CLR 1502, a cancer
3 Biotech Stocks That Could Double Overnight - Wealth ... CLRB stock may be a terrible idea for a retirement account. In fact, it’s down nearly 50% overall in the past year. But if you’re looking to trade stocks that could double overnight, CLRB’s tiny float and extremely high short interest make it worth a look. CLRB Split History Cellectar Biosciences (CLRB) has 2 splits in our CLRB split history database. The first split for CLRB took place on March 07, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of CLRB owned pre-split, the shareholder now owned 1 share. Cellectar Biosciences Inc. (CLRB) Stock Message Board ... Mar 16, 2020 · Our proprietary phospholipid ether (PLE) platform technology features include the capacity to link to a wide variety of warheads, provide a significant increase in targeted oncologic warhead delivery and the ability to target all tumor cells. CLRX Stock Quote - Rennova Health Inc - Bloomberg Markets
Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. CLRB - Research and Analysis for CELLECTAR BIOSCIENCES ... In-depth view of key statistics and finances for CELLECTAR BIOSCIENCES, INC. (CLRB) on MSN Money. CLRB Stock | Message Board | Cellectar Biosciences, Inc ... CLRB Stock Message Board for Investors. Cellectar Biosciences, Inc. Stock Price, News and Company Updates. Message Board Total Posts: 34 DOCRF vs. CLRB Stock Research Comparison DOCRF (CloudMD Software & Services Inc.) vs. CLRB (Cellectar Biosciences, Inc.) stock comparison side-by-side research /w SpeculatingStocks FREE tool. Side-by-side comparison between CloudMD Software & Services Inc. (DOCRF) and Cellectar Biosciences, Inc. (CLRB) …
13 Feb 2020 Check out my preferred stock broker for small day trading accounts of less than $5k that are Day Trader FRIENDLY $CLRB -$419.24 4 Nov 2018 Full daily historic prices of 5800+ stocks on NASDAQ and NYSE listings. Unzip fh< versiondate >.zip; Each stock symbol has a .csv file under full_history/ low - float, lowest price of the day; adjclose - float, adjusted closing price CUZ DMO S CLRB CKH HGH AVD PAAS FMNB PSXP CLDC FLMN NXN